Biology of interleukin-5 in ocular cicatricial pemphigoid

Graefe's Archive for Clinical and Experimental Ophthalmology

Volumn 240, Issue 7, 2002, Pages 565-569

  Letko, Erik ^a,b,c   Bhol, Kailash ^a,b   Colon, Jose ^a,b   Foster, C Stephen ^c   Ahmed, A Razzaque ^a,b  

^a HARVARD SCHOOL OF DENTAL MEDICINE   (United States)

^b NEW ENGLAND BAPTIST HOSPITAL   (United States)

^c MASSACHUSETTS EYE AND EAR INFIRMARY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOPHOSPHAMIDE; CYTARABINE; DAPSONE; IMMUNOSUPPRESSIVE AGENT; INTERLEUKIN 5; METHOTREXATE; PREDNISONE; TACROLIMUS;

ADULT; AGE; AGED; ARTICLE; BLOOD; CATARACT EXTRACTION; CHRONIC DISEASE; CLINICAL ARTICLE; CONJUNCTIVAL BIOPSY; CONJUNCTIVITIS; CONTROLLED STUDY; DISEASE ACTIVITY; EOSINOPHIL; EYE DISEASE; FEMALE; GENDER; HUMAN; HUMAN CELL; HUMAN TISSUE; LEUKOCYTE COUNT; MALE; MAST CELL; MICROSCOPY; MUCOUS MEMBRANE PEMPHIGOID; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RACE; STATISTICAL SIGNIFICANCE;

EID: 0036956315     PISSN: 0721832X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00417-002-0497-4     Document Type: Article

References (17)

1. Aldenborg F, Nilsson K, Jarlshammar B, et al (1993) Mast cells and biogenic amines in radiation-induced pulmonary fibrosis. Am J Respir Cell Mol Biol 8:112-117
2. Chan RY, Bhol K, Tesavibul N, et al (1999) The role of antibody to human β4-integrin in conjunctival basement membrane separation: possible in vitro model for ocular cicatricial pemphigoid. Invest Ophthalmol Vis Sci 40:2283-2290
3. Dubertret L, Bertaux B, Fosse M, Touraine R (1980) Cellular events leading to blister formation in bullous pemphigoid. Br J Dermatol 103:615-624
4. Elder MJ, Dart JK, Lightman S (1997) Conjunctival fibrosis in ocular cicatricial pemphigoid. Exp Eye Res 65:165-176
5. Engineer L, Bhol K, Kumari S, Ahmed AR (2001) Bullous pemphigoid: interaction of interleukin-5, anti-basement membrane zone antibodies and eosinophils. A preliminary observation. Cytokine 13:32-38
6. Foster CS (1986) Cicatricial pemphigoid. Trans Am Ophthalmol Soc 84:527-663
7. Heiligenhaus A, Schaller J, Mauss S, et al (1998) Eosinophil granule proteins expressed in ocular cicatricial pemphigoid. Br J Ophthalmol 82:312-317
8. Karlen S, De Boer ML, Lipscombe RJ, et al (1998) Biological and molecular characteristics of interleukin-5 and its receptor. Int Rev Immunol 16:227-247
9. Kumari S, Bhol KC, Rehman F, Foster CS, Ahmed AR (2001) Interleukin-1 components in cicatricial pemphigoid. Role in intravenous immunoglobulin therapy. Cytokine 4:218-224
10. Lee SJ, Li Z, Sherman B, Foster CS (1993) Serum levels of tumor necrosis factor-alpha and interleukin-6 in ocular cicatricial pemphigoid. Invest Ophthalmol Vis Sci 34:3522-3525
11. Leonardi A, Bloch KJ, Briggs R, Allansmith MR (1990) Histology of ocular late-phase reaction in guinea pigs passively sensitized with IgGl antibodies. Ophthalmic Res 22:209-219
12. Letko E, Bhol K, Foster CS, Ahmed AR (2000) Influence of intravenous immunoglobulin on serum levels of anti-beta4 antibodies in ocular cicatricial pemphigoid. A correlation with disease activity. A preliminary study. Curr Eye Res 21:646-654
13. Möller A, Grabbe J, Czarnetzki BM (1991) Mast cells and their mediators in immediate and delayed immune reactions. Skin Pharmacol Suppl 1:56-63
14. Nakamura A, Yamazaki K, Suzuki K, Sato S, et al (1997) Increased portal tract infiltration of mast cells and eosinophils in primary biliary cirrhosis. Am J Gastroenterol 92:2245-2249
15. Raible DG, Schulman ES, DiMuzio J, et al (1992) Mast cell mediators prostaglandin-D2 and histamine activate human eosinophils. J Immunol 148:3536-3542
16. Roboz GJ, Rafii S, et al (1999) Interleukin-5 and the regulation of eosinophil production. Curr Opin Hematol 6:164-168
17. Wintroub BU, Mihm MC Jr, Goetzl EJ (1978) Morphologic and functional evidence for release of mast-cell products in bullous pemphigoid. N Engl J Med 298:417-421